Form D · Other Technology

Algenesis Corp

San Diego, CA · CIK 0001856215

Offering snapshot reported Oct 25, 2024 · SEC filing

Reported sold
$3M
Offering amount: $3M
Investors reported
22
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 18, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 25, 2024Initial$3,000,000No comparison22SEC filing
Dec 18, 2023Amendment$5,000,000$3,699,383vs May 8, 202325SEC filing
May 8, 2023Initial$1,300,617No comparison13SEC filing
Jul 11, 2022Initial$847,125No comparison25SEC filing
Apr 16, 2021Initial$2,368,026No comparison48SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-527861

Source: Form D, filed Oct 25, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Burkart Promoter
Thomas Cooke Director, Executive
Daniel Dearen Director
Nancy Dynan Director
Wolfgang Hafenmayer Director
Stephen Mayfield Director, Executive, Promoter
Peter Morgan Executive, Promoter
Robert Pomeroy Promoter
Daniel Rosen Director
Nicholas Sandland Director, Executive
Veronica Wu Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
11760 Sorrento Valley Rd Suite J
San Diego, CA, 92121